Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Aug 13, 2025 · 10-Q · 44 days after period end · 0001640334-25-001429
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$3.22M | -$2.43M | -$1.60M | -$2.45M |
| EPS Diluted | -$16.86 | -$4.52 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 13, 2025 · 44 d after period end
